CAPTRUST Financial Advisors
NVAX icon

CAPTRUST Financial Advisors’s Novavax NVAX Stock Holding History

CAPTRUST Financial Advisors’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-6,703
Closed -$345K – 3352
2022
Q2 		$345K Buy
6,703
+3,047
+83% +$158K ﹤0.01% 1343
2022
Q1 		$269K Sell
3,656
-44
-1% -$3.92K ﹤0.01% 1519
2021
Q4 		$529K Buy
3,700
+1,133
+44% +$195K ﹤0.01% 1092
2021
Q3 		$532K Buy
2,567
+1,942
+311% +$428K ﹤0.01% 1001
2021
Q2 		$133K Buy
625
+16
+3% +$2.93K ﹤0.01% 1804
2021
Q1 		$110K Buy
609
+399
+190% +$79.5K ﹤0.01% 1885
2020
Q4 		$23K Buy
210
+27
+15% +$2.87K ﹤0.01% 2183
2020
Q3 		$19K Sell
183
-37
-17% -$4.51K ﹤0.01% 1998
2020
Q2 		$18K Buy
+220
New +$8.41K ﹤0.01% 1981

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

CAPTRUST Financial Advisors's NVAX Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of Novavax (NVAX) in Q3 2022, closing a stake of 6,703 shares — an estimated $345K sold.

CAPTRUST Financial Advisors first reported a position in NVAX in Q2 2020 and held it in 9 quarters. The position peaked at $532K in Q3 2021. 253 funds tracked by Wall St. Rank hold NVAX as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining Novavax position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 6,703 Novavax shares in Q3 2022, an estimated $345K.
  • CAPTRUST Financial Advisors first reported a position in Novavax in Q2 2020 and held it in 9 quarters.
  • CAPTRUST Financial Advisors's Novavax position peaked at $532K in Q3 2021.
  • 253 funds tracked by Wall St. Rank held Novavax as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.